Chuck Triano | Senior Vice President, Investor Relations |
Albert Bourla | Chairman & Chief Executive Officer |
Frank D'Amelio | Chief Financial Officer |
Mikael Dolsten | Chief Scientific Officer & President, Worldwide Research Development and Medical |
Angela Hwang | Group President, Pfizer Biopharmaceuticals Group |
Umer Raffat | Evercore |
Vamil Divan | Mizuho |
Gregg Gilbert | Truist |
Terence Flynn | Goldman Sachs |
Geoffrey Porges | SVB Leerink |
Louise Chen | Cantor |
Navin Jacob | UBS |
Chris Schott | JPMorgan |
Steve Scala | Cowen |
Tim Anderson | Wolfe Research |
Randall Stanicky | RBC Capital Markets |
David Risinger | Morgan Stanley |
Andrew Baum | Citi |
Good day everyone and welcome to Pfizer's Third Quarter 2020 Earnings Conference Call. Today's call is being recorded. At this time, I would like to turn the call over to Mr. Chuck Triano, Senior Vice President of Investor Relations. Please go ahead sir.